UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

Discover research-backed methods to speed up healing after getting stitches. From optimal nutrition to proper wound care, ...

We all encounter gels in daily life-from the soft, sticky substances you put in your hair, to the jelly-like components in ...

Scientists have created a self-healing hydrogel that mimics human skin, offering a breakthrough solution for complete wound ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

“Entanglement means that the thin polymer layers start to twist around each other like tiny wool yarns, but in a random order ...

Stanford researchers recently announced promising animal studies for a hydrogel they developed to prevent post-surgery ...

SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...

The gel is designed to be a 'safe' debrider ... for factors that may influence debridement as well as healing of the wound. This will precede the confirmatory Phase III trials necessary for ...